Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ERAP2 | Q6P179 | 1/20 | 0.52 |
| ▸ | LNPEP | Q9UIQ6 | 1/20 | 0.52 |
| ▸ | BACE1 | P56817 | 7/20 | 0.50 |
| ▸ | BACE2 | Q9Y5Z0 | 2/20 | 0.50 |
| ▸ | CTSD | P07339 | 1/20 | 0.50 |
| ▸ | MMP2 | P08253 | 1/20 | 0.50 |
| ▸ | MME | P08473 | 1/20 | 0.49 |
| ▸ | NAALAD2 | Q9Y3Q0 | 1/20 | 0.49 |
| ▸ | LTA4H | P09960 | 1/20 | 0.49 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.49 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29692934 | 0.95 | ERAP2 (0.57) | ERAP2LNPEPMMP2NAALAD2LTA4H | |
| SCHEMBL29774693 | 0.93 | GNPAT (0.56) | ERAP2LNPEPMMP2NAALAD2LTA4H | |
| SCHEMBL29774691 | 0.93 | GNPAT (0.56) | ERAP2LNPEPMMP2NAALAD2LTA4H | |
| SCHEMBL30099583 | 0.93 | GNPAT (0.56) | ERAP2LNPEPMMP2NAALAD2LTA4H | |
| SCHEMBL30099620 | 0.93 | GNPAT (0.56) | ERAP2LNPEPMMP2NAALAD2LTA4H | |
| SCHEMBL30099615 | 0.93 | GNPAT (0.56) | ERAP2LNPEPMMP2NAALAD2LTA4H | |
| SCHEMBL29763133 | 0.92 | BACE1 (0.53) | ERAP2LNPEPBACE1CTSDNAALAD2 | |
| SCHEMBL29763124 | 0.92 | BACE1 (0.53) | ERAP2LNPEPBACE1CTSDNAALAD2 | |
| SCHEMBL30740082 | 0.91 | NAALAD2 (0.56) | ERAP2LNPEPMMP2NAALAD2LTA4H | |
| SCHEMBL30799162 | 0.91 | ERAP2 (0.52) | ERAP2LNPEPMMP2MMELTA4H |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11807899-B2 | Biochemical reaction methods and reagents comprising intrinsically disordered regions | Biocrucible Limited | 2023-11-07 | — | — | US | disclosed |
| US-20220145378-A1 | BIOCHEMICAL REACTION METHODS AND REAGENTS COMPRISING INTRINSICALLY DISORDERED REGIONS | Biocrucible Limited (GB) | 2022-05-12 | — | — | US | disclosed |